John W. Rogers Jr. - Ariel Appreciation Fund 13F Activity & Position Changes (Q2 2024)

As of Jun 30, 2024, the Ariel Appreciation Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 14, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2024, the filing reported:

New Buys - Allstate Corporation (The), D.R. Horton, Inc., Joint Stock Company Kaspi.kz - , Lennar Corporation, Labcorp Holdings Inc., and 1 more

Increases - ADT Inc., Affiliated Managers Group, Inc., APA Corporation, Bio-Rad Laboratories, Inc., Boyd Gaming Corporation, and 35 more

Reductions - AFLAC Incorporated, Adtalem Global Education Inc., Axalta, Bank of America Corporation, Credicorp, and 63 more

Complete Exits - Horace Mann Educators Corporati, iShares Russell Mid-cap Value E, TIM S.A., Vodafone Group Plc, Vanguard FTSE Emerging Markets

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q2 2024	ADT ADT Inc.	ADT Inc.	Buy	+780,762	+2.6%	$230.74M	30,360,559
Q2 2024	AFL AFLAC Incorporated	AFLAC Incorporated	Sell	-21,159	-3.9%	$46.17M	516,974
Q2 2024	ALL Allstate Corporation (The)	Allstate Corporation (The)	Buy - Position Entry	+240,042	-	$38.33M	240,042
Q2 2024	AMG Affiliated Managers Group, Inc.	Affiliated Managers Group, Inc.	Buy	+115,808	+8.7%	$225.41M	1,442,817
Q2 2024	APA APA Corporation	APA Corporation	Buy	+18,406	+9.6%	$6.18M	209,848
Q2 2024	ATGE Adtalem Global Education Inc.	Adtalem Global Education Inc.	Sell	-137,584	-4.5%	$200.66M	2,941,733
Q2 2024	AXTA Axalta	Axalta	Sell	-68,923	-1.5%	$150.59M	4,406,964
Q2 2024	BAC Bank of America Corporation	Bank of America Corporation	Sell	-5,197	-2.9%	$6.83M	171,684
Q2 2024	BAP Credicorp	Credicorp	Sell	-141,705	-25.7%	$66.09M	409,636
Q2 2024	BCO Brinks Company (The)	Brinks Company (The)	Sell	-442,124	-25.8%	$130.11M	1,270,577
Q2 2024	BIDU Baidu, Inc.	Baidu, Inc.	Sell	-46,469	-4.1%	$94.54M	1,093,252
Q2 2024	BIO Bio-Rad Laboratories, Inc.	Bio-Rad Laboratories, Inc.	Buy	+39,095	+60.1%	$28.45M	104,187
Q2 2024	BMY Bristol-Myers Squibb Company	Bristol-Myers Squibb Company	Sell	-14,902	-2.4%	$25.72M	619,211
Q2 2024	BOKF BOK Financial Corporation	BOK Financial Corporation	Sell	-239,164	-11.1%	$175.51M	1,915,225
Q2 2024	BRC Brady Corporation	Brady Corporation	Sell	-10,223	-3.5%	$18.42M	279,010
Q2 2024	BWA BorgWarner Inc.	BorgWarner Inc.	Sell	-76,619	-7.6%	$29.86M	926,171
Q2 2024	BYD Boyd Gaming Corporation	Boyd Gaming Corporation	Buy	+335,984	+12.5%	$167.05M	3,031,691
Q2 2024	CBRE CBRE Group Inc	CBRE Group Inc	Sell	-220,454	-31.3%	$43.22M	484,995
Q2 2024	CG The Carlyle Group Inc.	The Carlyle Group Inc.	Buy	+54,805	+1.1%	$198.25M	4,937,725
Q2 2024	CHKP Check Point	Check Point	Sell	-46,255	-3.3%	$220.49M	1,336,278
Q2 2024	CLB Core Laboratories Inc.	Core Laboratories Inc.	Sell	-533,361	-4.9%	$208.83M	10,292,296
Q2 2024	CNH CNH Industrial	CNH Industrial	Buy	+417,098	+16.6%	$29.72M	2,933,416
Q2 2024	COF Capital One Financial Corporati	Capital One Financial Corporati	Buy	+172,611	+65.5%	$60.41M	436,335
Q2 2024	CRL Charles River Laboratories Inte	Charles River Laboratories Inte	Sell	-26,670	-2.9%	$187.19M	906,137
Q2 2024	CVS CVS Health Corporation	CVS Health Corporation	Buy	+62,475	+10.3%	$39.52M	669,084
Q2 2024	CVX Chevron Corporation	Chevron Corporation	Sell	-62	-0.2%	$5.10M	32,601
Q2 2024	DHI D.R. Horton, Inc.	D.R. Horton, Inc.	Buy - Position Entry	+165,626	-	$23.34M	165,626
Q2 2024	DNB Dun & Bradstreet Holdings, Inc.	Dun & Bradstreet Holdings, Inc.	Sell	-153,685	-3.5%	$38.82M	4,192,449
Q2 2024	DVA DaVita Inc.	DaVita Inc.	Sell	-256,666	-41.6%	$49.83M	359,604
Q2 2024	EVR Evercore Inc.	Evercore Inc.	Sell	-5,022	-4.0%	$25.27M	121,221

Page 1 of 4